Tags: biotechnology, Infectious Diseases, prostate cancer, vaccines
Bavarian Nordic is an international biotechnology headquartered in Denmark. Read the full story
Tags: big pharma, partnering, points of view, vaccines
Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years there has been a significant increase in vaccine partnering and M&A activity.
Read the full story
Tags: big pharma, industry analysis, oncology, vaccines
Recent trends analysis suggests that research in personalized medicine and vaccine development for disease treatment has increased partnering and collaboration in this arena. Read the full story
Tags: glossary, vaccines
A vaccine is a biological preparation that improves immunity to a particular disease. Read the full story
Tags: biotech, cancer, vaccines
A cancer vaccine is a vaccine that treats existing cancer or prevents the development… Read the full story
Tags: glossary, therapy, vaccines
A vaccine is a biological preparation that improves immunity to a particular disease Read the full story
Tags: animal health, asset purchase, Eli Lilly, GSK, Novartis, oncology, vaccines
Novartis signs pharma deal with GlaxoSmithKline and Eli Lilly for exchange of oncology, vaccine and animal health business units. Read the full story
Tags: cancer, co-development, pharma alliances, Roche, vaccines
immatics biotechnologies forms a pharma alliances with Roche for a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics for $1.017billion.
Tags: big pharma, GlaxoSmithKline, pharma alliances, vaccines
GlaxoSmithKline and Sanofi have both signed for a pharma alliances to work with the Bill & Melinda Gates Foundation.
Tags: big pharma, CSL, partnering, vaccines
CSL is a large speciality biopharmaceutical company developing and manufacturing plasma products and vaccines to treat and protect patients worldwide. Read the full story
Home | Reports | Services | Insight | News | Events | Scorecard | About us | Terms & conditions | Subscribe | Contact us
© 2014 Wildwood Ventures Ltd.